New paper
Research progress of pancreatic cancer based on ferroptosis-cuproptosis interaction (Review)
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
p38α Signaling Is Associated with Pancreatic Ductal Adenocarcinoma Progression and Represents a Potential Therapeutic Vulnerability.
Why it was picked newest record on or before this date
New paper
IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma.
Why it was picked newest record on or before this date
New paper
Chaihu Shugan San Inhibits Pancreatic Cancer Invasion and Migration by Targeting the Snail/ZEB1-Mediated Epithelial–Mesenchymal Transition
Why it was picked newest record on or before this date
New paper
Targeting pancreatic cancer with adenoviral vectors equipped with transgenes.
Why it was picked newest record on or before this date
Also today
New paper
Metastatic pancreatic cancer: from human disease to preclinical modelling.
New paper
When immunotherapy mimics pancreatic cancer: mass-forming immune-related pancreatitis during neoadjuvant treatment for triple-negative breast cancer.
New paper
Prognostic impact of imaging tumor regression adjacent to major arteries after preoperative chemotherapy in surgical patients with advanced pancreatic cancer.
New paper
Corrigendum to "Cancer cell membrane-modified Soluplus® micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach" [Int. J. Pharm. 662 (2024) 124529].
Editor’s note
Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.